PROF. DR. MED CHRISTOPH RENNER

DIRECTOR & CoFounder

Professor of Medical Oncology at the University of Basel, and a senior physician specialist in Oncology, Onco-immunology and internal medicine at Hirslanden Hospital Zurich. CR is a member of different research organizations and has served for six years on the board of the Swiss Group for Clinical Cancer Research. CR is currently consulting for four biotech companies as a scientific advisor with one being listed on the NASDAQ exchange​

Board of Directors

DR. OSIRIS MARROQUIN BELAUNZARAN

CHAIRMAN & COFOUNDER 

Dr. Marroquin-Belaunzaran has more than 13 years of research and development experience in Immuno-oncology and Autoimmunity. He has led various programs in product development for immuno-oncology therapeutics and expertise across multiple areas of drug discovery, drug delivery systems, protein engineering, antibody development, and pre-clinical development of therapeutics in diverse animal models of cancer, autoimmunity, and neurology. His extensive work led to multiple discoveries of a novel class of human immunomodulatory agents for treating cancer and infectious diseases.  He has a Ph.D. in Bioengineering and Biotechnology from EPFL Lausanne, Switzerland

SEAN R. SMITH

DIRECTOR

Mr. Smith became CEO of ImmunOs Therapeutics AG after recently spending over 15 years at MSD/Merck and Co., Inc in positions of increasing responsibility in commercial leadership, cross-departmental management, business development, country, and regional operations with broad exposure to multiple therapeutic areas including early-stage clinical, in-line, and launch portfolios in Hospital/Specialty, Infectious Disease, General Medicine, and Vaccines. He has extensive leadership experience in global markets focused in North America, Europe, Asia-Pacific, China, Japan, and Latin America. Mr. Smith received his B.S. from Pennsylvania State University and M.B.A. from the University of Denver